Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1942 1
1943 2
1946 1
1948 6
1949 2
1950 2
1951 1
1952 1
1953 1
1955 1
1956 1
1957 3
1958 4
1959 3
1960 6
1961 3
1962 2
1963 5
1964 4
1965 6
1966 5
1967 9
1968 3
1969 6
1970 7
1971 7
1972 9
1973 6
1974 8
1975 17
1976 15
1977 31
1978 24
1979 27
1980 46
1981 28
1982 34
1983 60
1984 58
1985 59
1986 60
1987 57
1988 88
1989 89
1990 83
1991 73
1992 95
1993 98
1994 81
1995 89
1996 102
1997 129
1998 141
1999 103
2000 131
2001 144
2002 140
2003 185
2004 165
2005 190
2006 185
2007 181
2008 204
2009 183
2010 196
2011 260
2012 288
2013 315
2014 304
2015 294
2016 380
2017 394
2018 400
2019 451
2020 527
2021 600
2022 589
2023 554
2024 567
2025 201

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

8,915 results

Results by year

Filters applied: . Clear all
Page 1
Intention-to-Treat Analysis of Hepatic Resection for Liver Metastases from Uveal Melanoma: A Single-Center Experience.
Maspero M, Pezzoli I, Di Guardo L, Angi M, Lo Dico S, Sposito C, Battiston C, Mazzaferro V. Maspero M, et al. Ann Surg Oncol. 2025 Apr 17. doi: 10.1245/s10434-025-17115-0. Online ahead of print. Ann Surg Oncol. 2025. PMID: 40246741
BACKGROUND: Uveal melanoma metastasizes to the liver in almost 50% of patients. The prognosis of liver metastases from uveal melanoma (LMUM) is dismal; however, results from retrospective monocentric series suggest that surgery may improve survival in …
BACKGROUND: Uveal melanoma metastasizes to the liver in almost 50% of patients. The prognosis of liver metastases from uvea
Protein Kinase C Inhibition Overcomes Targeted Therapy Resistance in Cutaneous Melanoma.
Stoffel CI, Eichhoff O, Cheng PF, Seiler L, Tellenbach F, Dzung A, Chiovaro F, Dummer R, Levesque MP. Stoffel CI, et al. Exp Dermatol. 2025 Apr;34(4):e70093. doi: 10.1111/exd.70093. Exp Dermatol. 2025. PMID: 40243348
Promising results of targeting non-canonical WNT5a-dependent WNT signalling with a pan-PKC inhibitor in uveal melanoma prompted us to investigate the relevance of PKC inhibition in cutaneous melanoma. ...
Promising results of targeting non-canonical WNT5a-dependent WNT signalling with a pan-PKC inhibitor in uveal melanoma prompte …
Novel Risk Factors for Uveal Melanoma in Adolescent and Young Adult Patients: A Comprehensive Case-Control Analysis.
Nisanova A, Park SS, Amin A, Zako C, Wilson MD, Scholey J, Afshar AR, Tsai T, Char DH, Mishra KK. Nisanova A, et al. Ophthalmol Sci. 2024 Dec 24;5(4):100687. doi: 10.1016/j.xops.2024.100687. eCollection 2025 Jul-Aug. Ophthalmol Sci. 2024. PMID: 40242369 Free PMC article.

PURPOSE: To identify risk factors associated with uveal melanoma (UM) in adolescents and young adults (AYAs). DESIGN: A retrospective case-control study. ...The prevalence of oculodermal melanocytosis (P = 0.03) and family history of UM (P < 0.001) were significa

PURPOSE: To identify risk factors associated with uveal melanoma (UM) in adolescents and young adults (AYAs). DESIGN: A retros …
Genetic landscape of uveal melanoma in Southeast Asia: high 1q gains and unique patterns of metastasis risk.
Chen C, Wang MM, Lim AST, Heng EYH, Tien SL, Shen SY, Tan GSW, Chan JY, Chan ASY. Chen C, et al. Eye Vis (Lond). 2025 Apr 16;12(1):15. doi: 10.1186/s40662-025-00430-8. Eye Vis (Lond). 2025. PMID: 40241171 Free PMC article.
PURPOSE: This retrospective cohort study aims to investigate chromosomal aberrations in Southeast Asian (SEA) uveal melanoma (UM) patients, evaluate their impact on clinical outcomes, and compare findings with the TCGA-Uveal Melanoma (TCGA-UM) dataset …
PURPOSE: This retrospective cohort study aims to investigate chromosomal aberrations in Southeast Asian (SEA) uveal melanoma ( …
Digital PCR-based genetic profiling from vitreous fluid as liquid biopsy for primary uveal melanoma: a proof-of-concept study.
Nell RJ, Versluis M, Menger NV, Gelmi MC, Vu THK, Verdijk RM, Luyten GPM, Jager MJ, van der Velden PA. Nell RJ, et al. J Exp Clin Cancer Res. 2025 Apr 17;44(1):124. doi: 10.1186/s13046-025-03374-y. J Exp Clin Cancer Res. 2025. PMID: 40240901 Free PMC article.
BACKGROUND: Uveal melanoma is an aggressive ocular malignancy. Early molecular characterisation of primary tumours is crucial to identify those at risk of metastatic dissemination. ...In this study, we aim to evaluate the DNA content of vitreous fluid from eyes with …
BACKGROUND: Uveal melanoma is an aggressive ocular malignancy. Early molecular characterisation of primary tumours is crucial …
Evolution of the tumor immune landscape during treatment with tebentafusp, a T cell receptor-CD3 bispecific.
Sacco JJ, Kirk P, Leach E, Shoushtari AN, Carvajal RD, Britton-Rivet C, Khakoo S, Collins L, de la Cruz-Merino L, Eroglu Z, Ikeguchi AP, Nathan P, Hamid O, Butler MO, Stanhope S, Ranade K, Sato T. Sacco JJ, et al. Cell Rep Med. 2025 Apr 15;6(4):102076. doi: 10.1016/j.xcrm.2025.102076. Cell Rep Med. 2025. PMID: 40239619 Clinical Trial.
Metastatic uveal melanoma is an aggressive disease with poor outcome, which is refractory to immune checkpoint inhibitors. A T cell receptor (TCR)-based CD3 bispecific, tebentafusp, delivers clinical benefit in patients with metastatic uveal melanoma. …
Metastatic uveal melanoma is an aggressive disease with poor outcome, which is refractory to immune checkpoint inhibitors. A T …
Radiotherapy has a survival advantage over surgery in patients with choroidal melanoma: a retrospective cohort study of 6,871 patients.
Wu Y, Shi L, Ye Z, Zhou Y, Wang F, Zhang Y. Wu Y, et al. Front Surg. 2025 Apr 1;12:1577775. doi: 10.3389/fsurg.2025.1577775. eCollection 2025. Front Surg. 2025. PMID: 40236990 Free PMC article.
BACKGROUND: Choroidal melanoma is a rare yet aggressive ocular malignancy, accounting for approximately 85% of all ocular melanomas. ...Choroidal melanoma-specific mortality was estimated using the competing risk regression method of Fine and Gray. ...
BACKGROUND: Choroidal melanoma is a rare yet aggressive ocular malignancy, accounting for approximately 85% of all ocular mela …
Beyond Checkpoint Inhibition: Keeping Therapeutic Options Open.
Joshi UM, Hundal J, Mata JR, Schollenberger MD, Warrier G, Luke JJ, Lipson EJ, Funchain P. Joshi UM, et al. Am Soc Clin Oncol Educ Book. 2025 Jun;45(3):e473856. doi: 10.1200/EDBK-25-473856. Epub 2025 Apr 15. Am Soc Clin Oncol Educ Book. 2025. PMID: 40233298 Free article. Review.
As a therapy which is limited to patients who are HLA-A*02:01, T-cell receptor (TCR) engineered T cells (TCR-T) iterates on personalized adoptive cell transfer, and immune mobilizing monoclonal TCRs against cancer are CD3 bispecifics that bind glycoprotein 100 (tebentafusp, appro …
As a therapy which is limited to patients who are HLA-A*02:01, T-cell receptor (TCR) engineered T cells (TCR-T) iterates on personalized ado …
Retrospective analysis of complications in enucleated patients with porous polyethylene implants for uveal melanoma.
López Miñarro I, García Álvarez C, Muñoz Moreno MF, Prieto Domínguez L, Saornil Álvarez MA. López Miñarro I, et al. Eur J Ophthalmol. 2025 Apr 15:11206721251334701. doi: 10.1177/11206721251334701. Online ahead of print. Eur J Ophthalmol. 2025. PMID: 40232263
PurposeThis study aimed to assess the complication rate of porous polyethylene (PP) implants in patients who underwent enucleation for uveal melanoma and to explore the link between complications and surgical factors.MethodsA retrospective cohort study was conducted …
PurposeThis study aimed to assess the complication rate of porous polyethylene (PP) implants in patients who underwent enucleation for uv
8,915 results